Brody's human pharmacology : mechanism-based therapeutics

著者

書誌事項

Brody's human pharmacology : mechanism-based therapeutics

Lynn Wecker, with David A. Taylor, Robert J. Theobald, Jr.

Elsevier, c2019

6th ed

  • : pbk

タイトル別名

Brody's human pharmacology : molecular to clinical

Human pharmacology

大学図書館所蔵 件 / 全6件

この図書・雑誌をさがす

注記

Previous ed. published under title: Brody's human pharmacology : molecular to clinical

Includes bibliographical references and index

内容説明・目次

内容説明

Focusing on the essential aspects of pharmacology you need to know, Brody's Human Pharmacology, 6th Edition, keeps you fully up to date with all that's new in the field. Streamlined content, a new organizational approach, enhanced online components, and thoroughly updated information ensure your grasp of key concepts and prepare you for exams. Nearly 500 full-color illustrations explain important processes, while color-coded boxes for major drugs, therapeutic overviews, clinical problems, and trade names reinforce your mastery of the information. The 6th Edition of this easy-to-use text is now fully up to date with: NEW chapter devoted entirely to pharmacogenomics and personalized medicine. NEW chapter on cannabinoids and their use for pain and other disorders, in light of recent legalization in many states. NEW chapters on recent developments in the treatment of Alzheimer's disease, ADHD and the latest treatments for HIV. NEW section on pain management. NEW section in each chapter covering "Clinical Relevance for Healthcare Professionals" that provides important information specific to physical therapists, dentists and dental hygienists, and many other medical professionals. Plus these student-friendly features: A new organizational approach, focusing on integration and systems-based learning. Contributions from leading faculty who cover the most important aspects of pharmacology necessary for a basic understanding of the subject, including concepts, clinical applications, and side effects. USMLE-style self-assessment questions at the end of every chapter, answers and rationales in the Appendix. Online access to Student Consult?where you'll find the complete contents of the book, fully searchable...150 USMLE-style questions...and more.

目次

Section 1 Mechanisms of Drug Action and Therapeutic Principles 1. Introduction, Terminology 2. Pharmacodynamics: Drug Targets (Receptors, Enzymes, DNA, etc) 3. Pharmacokinetics 4. Pharmacogenomics 5. Drug Discovery, Development, and Regulation Section 2 Chemical Mediators and Drugs Affecting Autonomic and Neuromuscular Synapses 6. Introduction to the Peripheral Nervous Systems and Drugs for Peripheral Disorders Cholinergic Drugs 7. Muscarinic Agonists and Their Clinical Uses 8. Muscarinic Antagonists and Their Clinical Uses 9. Nicotinic Agonists and Their Clinical Uses 10. Nicotinic Antagonists and Neuromuscular Blocking Drugs Adrenergic Drugs 11. Adrenergic Agonists and Their Clinical Uses 12. Adrenergic Antagonists and Their Clinical Uses Section 3 Drug Treatment for Disorders Affecting the Central Nervous System 13. Introduction to the CNS and Drugs Affecting the Brain Neurodegenerative Disorders 14. Drug Therapy for Alzheimer's Disease and Other Cognitive Disorders/Dementias 15. Pharmacotherapy of Basal Ganglia Disorders: Parkinson's Disease and Huntington's Disease 16. Drug Therapy for Psychoses and Bipolar Disorder 17. Drug Therapy for Depression and Anxiety 18. Drug Therapy for the Management of Attention Deficit Hyperactivity Disorder 19. Drug Therapy for Insomnia and the Hypersomnias 20. Drug Therapy for Managing Obesity and Eating Disorders 21. Treatment of Seizure Disorders 22. Drug Therapy to Control Spasticity Disorders 23. Ethanol, Other Alcohols, and Drugs for Alcohol Use Disorder 24. Illicit Psychoactive Compounds and Substance Use Disorder Section 4 Drug Therapy for Pain Management 25. Introduction 26. General Anesthetics 27. Local Anesthetics 28. Opioid Analgesics 29. Nonsteroidal Anti-inflammatory Agents and Acetaminophen 30. Cannabinoids Section 5 Treatment of Inflammatory, Allergic and Immunologic Disorders 31. Drug Therapy for Migraine Headache 32. Drug Therapy for Gout and Hyperuricemia 33. Drug Treatment for Allergic Reactions 34. Immunosuppressants for Autoimmune Disorders and Organ Transplantation 35. Drug Therapy for Rheumatoid Arthritis Section 6 Drug Treatment for Cardiovascular Diseases 36. Introduction to The Cardiovascular System and the Regulation of Blood Pressure and Heart Rate 37. Overview of Hypertension Management and Drugs that Decrease Sympathetic Tone 38. Diuretics and Drugs that Affect Volume and Electrolyte Content 39. Drugs Affecting the Renin-Angiotensin-Aldosterone System 40. Calcium Channel Blockers 41. Vasodilators 42. Drug Therapy for Hyperlipidemias and Atherosclerotic Cardiovascular Disease 43. Drug Therapy for Myocardial Ischemia and Angina Pectoris 44. Treatment of Heart Failure: Cardiac Glycosides, Phosphodiesterase Inhibitors and Other Agents 45. Antiarrhythmic Drugs 46. Anticoagulant, Antiplatelet and Thrombolytic Agents 47. Drug Therapy for Hemophilia and the Anemias Section 7 Treatment of Endocrine Disorders 48. Introduction to Endocrine Pharmacology 49. Treatment of Hypothalamic and Pituitary Disorders 50. Treatment of Adrenalcorticosteroid Disorders 51. Female Hormone Regulation 52. Androgens, antiandrogens and their clinical uses 53. Drug Therapy for the Management of Diabetes 54. Drug Therapy for the Management of Thyroid Disorders 55. Calcium Regulating Hormones and Agents Affecting Bone Section 8 Chemotherapy Infectious Diseases 56. Principles of Antimicrobial Use 57. Bacterial Cell Wall Synthesis Inhibitors 58. Inhibitors of Protein Synthesis 59. Drugs that Target DNA 60. Antimycobacterial Drugs and the Treatment of Tuberculosis and Leprosy 61. Drug Therapy for Resistant Organisms Parasitic Diseases 62. Antifungal Agents 63. Antimalarial and Other Antiprotozoal Agents 64. Antihelmintics Viruses 65. Drug Therapy for non-HIV Viral Infections 66. Drugs for HIV and Related Opportunistic Infections Cancer 67. Introduction and Therapeutic Principles 68. Cytotoxic Agents 69. Targeted Agents Section 9 Special Considerations 70. Therapeutic Use of Hematopoietic Growth Factors, Vitamins and Minerals 71. Gastrointestinal Disorders and Their Treatment 72. Pharmacological Treatment of Asthma and COPD 73. The Role of Neutraceuticals and Natural Products 74. Essentials of Toxicology 75. Therapeutic Considerations for Pregnant, Pediatric, Geriatric and Obese Individuals

「Nielsen BookData」 より

詳細情報

ページトップへ